The management of patients with uterine sarcoma: a debated clinical challenge
A Gadducci, S Cosio, A Romanini… - Critical reviews in …, 2008 - Elsevier
Uterine sarcomas include a heterogeneous group of rare tumours that usually have an
aggressive clinical behaviour and a poor prognosis. Total abdominal hysterectomy and …
aggressive clinical behaviour and a poor prognosis. Total abdominal hysterectomy and …
Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management
R Kanthan, JL Senger - Obstetrics and gynecology international, 2011 - Wiley Online Library
Uterine carcinosarcomas (MMMT—malignant mixed Müllerian tumours) are highly
aggressive, rare, biphasic tumours composed of epithelial and mesenchymal elements …
aggressive, rare, biphasic tumours composed of epithelial and mesenchymal elements …
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for …
NS Reed, C Mangioni, H Malmström, G Scarfone… - European Journal of …, 2008 - Elsevier
The management of uterine sarcomas continues to present many difficulties. Primary
surgery is the optimal treatment but the role of post-operative radiation remains uncertain. In …
surgery is the optimal treatment but the role of post-operative radiation remains uncertain. In …
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in …
AH Wolfson, MF Brady, T Rocereto, RS Mannel… - Gynecologic …, 2007 - Elsevier
PURPOSE: After initial surgery, there has been no established consensus regarding
adjunctive therapy for patients with uterine carcinosarcoma (CS). This study was designed to …
adjunctive therapy for patients with uterine carcinosarcoma (CS). This study was designed to …
Prognostic features of surgical stage I uterine carcinosarcoma
SE Ferguson, C Tornos, A Hummer… - The American journal …, 2007 - journals.lww.com
Uterine carcinosarcomas (CSs) are aggressive neoplasms, with 5-year overall survival (OS)
rates of less than 35%. They are customarily separated into types harboring either …
rates of less than 35%. They are customarily separated into types harboring either …
Persistent Hypomethylation in the Promoter of Nucleosomal Binding Protein 1 (Nsbp1) Correlates with Overexpression of Nsbp1 in Mouse Uteri Neonatally Exposed …
WY Tang, R Newbold, K Mardilovich… - …, 2008 - academic.oup.com
Neonatal exposure of CD-1 mice to diethylstilbestrol (DES) or genistein (GEN) induces
uterine adenocarcinoma in aging animals. Uterine carcinogenesis in this model is ovarian …
uterine adenocarcinoma in aging animals. Uterine carcinogenesis in this model is ovarian …
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma
K Galaal, E van der Heijden, K Godfrey… - Cochrane Database …, 2013 - cochranelibrary.com
Background Uterine carcinosarcomas are uncommon with about 35% not confined to the
uterus at diagnosis. The survival of women with advanced uterine carcinosarcoma is poor …
uterus at diagnosis. The survival of women with advanced uterine carcinosarcoma is poor …
Uterine carcinosarcoma
SA El-Nashar, A Mariani - Clinical obstetrics and gynecology, 2011 - journals.lww.com
Carcinosarcoma is a rare but highly aggressive uterine malignancy. Pathologically,
carcinosarcoma is a biphasic neoplasm composed of a mixture of malignant epithelial and …
carcinosarcoma is a biphasic neoplasm composed of a mixture of malignant epithelial and …
Review literature on uterine carcinosarcoma
R Singh - Journal of cancer research and therapeutics, 2014 - journals.lww.com
Carcinosarcoma of the uterus is a rare gynaecological neoplasm, which is also known as
malignant mixed mesodermal tumor. Traditionally this tumour has been regarded as a …
malignant mixed mesodermal tumor. Traditionally this tumour has been regarded as a …
Uterine carcinosarcoma
Uterine carcinosarcoma : Current Opinion in Oncology Uterine carcinosarcoma : Current Opinion
in Oncology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …
in Oncology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …